Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (43,776,220)	$ (26,766,572)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense	8,941,452	5,412,451
Depreciation and amortization	1,578,334	1,197,801
Changes in fair value of derivative liability	(23,175)	12,952
Change in acquisition-related contingent consideration	1,090,000	0
Bad debt recovery	(5,763)	(232,531)
Deferred income taxes	142,183	492,325
Accretion Expense	7,329	0
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(2,795,249)	(663,543)
Accounts receivable	(177,162)	(108,363)
Inventory	(872,079)	583,659
Unearned revenues	1,823,379	(446,399)
Other assets	559,470	421
Accounts payable, accrued liabilities and other liabilities	(2,483,740)	780,100
Net cash used in operating activities	(35,991,241)	(19,737,699)
Cash flows from investing activities:
Net cash received in acquisitions	50,894	0
Purchase of marketable securities	(920,329)	0
Proceeds from Sale and Maturity of Marketable Securities	248,000	0
Acquisition of property, plant and equipment	(2,925,918)	(948,644)
Net cash used in investing activities	(3,547,353)	(948,644)
Cash flows from financing activities:
Proceeds from exercise of options	271,008	86,658
Proceeds from exercise of warrants	1,720,725	2,126,291
Net proceeds from issuance of common stock	11,275,109	21,517,422
Proceeds from Issuance of Long-term Debt	14,476,170	0
Repayment of mortgage loan	(3,236,721)	(150,294)
Proceeds from notes payable	1,777,163	709,741
Repayment of notes payable	(737,333)	(332,713)
Payment for warrant inducement	0	(62,014)
Net cash provided by financing activities	25,546,121	23,895,091
Net (decrease) increase in cash and cash equivalents	(13,992,473)	3,208,748
Cash and cash equivalents at beginning of period	46,133,759	13,737,452
Cash and cash equivalents at beginning of period	32,141,286	16,946,200
Cash paid during the period for:
Interest	359,300	202,800
Taxes	0	0
Common stock and contingent consideration issued in merger	$ 33,490,351	$ 0